What should you know about triple-negative ovarian cancer?

Unlike breast cancer, ovarian cancer is not routinely grouped into one universal triple-negative category. The phrase may reflect a particular pathology report, a research term or confusion with breast cancer receptor language. The exact ovarian tumour type, grade, stage and genetic features matter more than the label alone.

Bloating, pelvic or abdominal discomfort, early fullness, urinary changes and altered bowel habits can occur, but these symptoms have many causes. Pelvic ultrasound and other investigations help assess an ovarian or pelvic abnormality; tissue diagnosis confirms the cancer type.

A gynaecological oncology team may discuss surgery, chemotherapy or both. Ovarian cancer debulking surgery removes as much visible tumour as safely possible in selected cases, and an oophorectomy removes one or both ovaries when indicated. The sequence depends on tumour distribution, health, operability and the pathology findings.

BRCA genetic testing and genomic tumour profiling can identify inherited or tumour-related features that may affect treatment choices and family discussions. Palliative care can help with pain, appetite, fatigue, mood and other symptoms at any stage alongside cancer treatment.

Arrange review for persistent bloating, pelvic pain, increasing abdominal size, unexplained weight change, or feeling full quickly. Seek urgent care for severe abdominal pain, repeated vomiting, fainting, heavy bleeding, fever or difficulty breathing. Symptoms alone cannot identify ovarian cancer, but persistence warrants assessment.

What exact ovarian tumour type and stage do I have? What does “triple-negative” mean in my report? Do I need BRCA testing or genomic profiling? Is surgery planned before chemotherapy, or after it? How can palliative care support symptoms during treatment?